Long non‑coding RNA LINC00460 contributes as a potential prognostic biomarker through its oncogenic role with ANXA2 in colorectal polyps

• Published in: Molecular biology reports 2023-05, Vol.50 (5), p.4505-4515
• Main Authors: Hosseini, Farzaneh Alsadat, Rejali, Leili, Zabihi, Mohammad Reza, Salehi, Zahra, Daskar-Abkenar, Elahe, Taraz, Tannaz, Fatemi, Nayeralsadat, Hashemi, Mehrdad, Asadzadeh-Aghdaei, Hamid, Nazemalhosseini-Mojarad, Ehsan
• Format: Article
• Language: English
• Subjects: Adenoma; Animal Anatomy; Animal Biochemistry; Annexin A2 - genetics; Annexin A2 - metabolism; Bioinformatics; Biomarkers; Biomedical and Life Sciences; Cancer; carcinogenesis; colon; Colonic Polyps - genetics; Colorectal cancer; Colorectal carcinoma; colorectal neoplasms; Histology; histopathology; Humans; Hypoxia-inducible factor 1a; Large intestine; Lesions; Life Sciences; MicroRNAs - genetics; miRNA; Morphology; neoplasm progression; non-coding RNA; oncogenes; Original Article; polymerase chain reaction; Polyps; Precancerous Conditions - genetics; Prognosis; Reverse transcription; RNA, Long Noncoding - genetics; RNA, Long Noncoding - metabolism
• ISSN: 0301-4851; 1573-4978
• DOI: 10.1007/s11033-023-08393-6

Background Long intergenic non-coding RNA 460 (LINC00460) as a potential oncogene and Annexin A2 ( ANXA2 ) as a promoter in different cancer progression processes was considered. A significant relationship between the LINC00460 and ANXA2 has been recently discovered in colorectal cancer (CRC). Therefore, defining molecular biomarkers accompanied by lesion histopathologic features can be a suggestive prognostic biomarker in precancerous polyps. This study aimed to investigate the elusive expression pattern of ANXA2 and LINC00460 in polyps. Materials and methods The construction of the co-expression and correlation network of LINC00460 and ANXA2 was plotted. LINC00460 and ANXA2 expression in 40 colon polyps was quantified by reverse transcription-real-time polymerase chain reaction. The receiver operating characteristic (ROC) curve was designed for distinguishing the high-risk precancerous lesion from the low-risk. Further, bioinformatics analysis was applied to find the shared MicroRNA-Interaction-Targets (MITs) between ANXA2 and LINC00460, and the associated pathways. Results ANXA2 has a high co-expression rank with LINC00460 in the lncHUB database. Overexpression of ANXA2 and LINC00460 was distinguished in advanced adenoma polyps compared to the adjacent normal samples. The estimated AUC for ANXA2 and LINC00460 was 0.88 − 0.85 with 93%-90% sensitivity and 81%-70% specificity. In addition, eight MITs were shared between ANXA2 and LINC00460. Enrichment analysis detected several GO terms and pathways, including HIF-1α associated with cancer development. Conclusion In conclusion, the expression of the ANXA2 and LINC00460 were significantly elevated in pre-cancerous polyps, especially in high-risk adenomas. Collectively, ANXA2 and LINC00460 may be administered as potential prognostic biomarkers in patients with a precancerous large intestine lesion as an alarming issue.